Silent Service, Loud Results: The Low-Drama Defense IT Name That Keeps Beating the Tape

What Just Happened, Without the Wonk

CACI International Inc. (NYSE: CACI) just had a fresh quarter with a clean print.

Earnings landed around $8.40 versus expectations closer to $6.60, with revenue a touch above $2.3B.

Management rolled out a measured FY26 outlook: mid-single-digit organic growth (roughly 4%–7%) and operating margins in the mid-11% range, essentially holding the line after an 11.2% margin year. 

The line that made my eyebrows go up was free cash flow: management pointed to >$700M for FY26, materially ahead of where many on the Street were modeling.

That’s more fuel for buybacks and small, high-fit tuck-in acquisitions.

Visibility remains the superpower. Backlog sits near $31.4B, which works out to roughly 3.5 years of revenue coverage.

It was flat sequentially and down ~1% year over year, which sounds ho-hum until you remember this is already a skyscraper of work.

The sheer scale matters: it smooths quarter-to-quarter noise and keeps the compounding machine fed.

Never Miss Our Top Tech Recommendations Again!

We now send our tech picks via text, too, so you’ll get the same tech breakout news without having to open your inbox.

👉 Click here to get stock picks by text and stay up to speed on the latest tech breakthroughs.

What They Do, In Plain English

Picture the places where bad latency, insecure networks, or outdated software would be a very expensive mistake: defense, intelligence, space, electronic warfare, secure enterprise IT.

That’s the neighborhood. 

CACI integrates mission software, analytics, cyber, spectrum operations, and space ground systems, then wraps it with cleared talent and program execution that survives the Pentagon’s paperwork obstacle course.

Once you’re inside a mission workflow, you’re hard to rip out. Renewals, recompetes, and follow-on scope are the rhythm of the business.

And yes, there’s AI in the mix, but not the slide-deck kind.

Think model-assisted analytics fused with legacy systems in classified environments where uptime and auditability beat flashy demos every time.

Breakout Picks Free (Sponsored)

5 Stocks Poised for Big Moves This Year

When markets shift, opportunities emerge.

But the best ones rarely stay hidden for long.

Our analysts have pinpointed 5 companies that stand out for their fundamentals, momentum, and potential to double from here.

You’ll find them inside the new 5 Stocks Set to Double report—free for a limited time.

Past versions of this report uncovered stocks that went on to massive gains of +175%, +498%, even +673%.¹

Today, you can download your copy instantly.

But once the clock strikes midnight, this free access closes.

[Grab your free report now]

Big winners don’t wait. Neither should you.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Why It Keeps Compounding While Others Wobble

There’s no magic here, just a sturdy loop. Awards stack into backlog. Backlog converts into revenue at a reliable cadence.

Revenue converts into cash because delivery discipline is the culture. 

Cash then buys back shares and funds targeted tuck-ins that either (a) raise margins, (b) deepen capability in growth lanes like cyber and EW, or (c) shorten sales cycles on future bids.

Rinse, repeat, ignore the drama.

A few numbers help frame the pattern.

Over the last couple of years, average backlog growth hovered in the low-teens, while buybacks nudged EPS growth above revenue growth. 

This isn’t financial engineering, it’s financial housekeeping. You keep costs tidy, retire stock, and let the backlog do the heavy lifting.

In a market obsessed with hero narratives, this one is stubbornly adult.

Rare Strength Seen (Sponsored)

These 7 Stocks Show Rare Strength

Some stocks take years to deliver results.

Others can move in weeks.

Right now, we’ve identified 7 stocks with the strongest short-term setups — and we’re giving you the full list for free.

This exclusive report, 7 Best Stocks for the Next 30 Days, highlights opportunities our research shows could be primed for immediate action.

[Click here to get the free list] before your next trade.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Where This Can Go Sideways

No story is risk-free, especially one tied to Washington’s calendar. The big three:

Timing, not demand. The government can turn a straight line into a pretzel, continuing resolutions, bid protests, and fiscal cliff theatrics.

Demand is there, but starts slip.

That pushes revenue from one quarter to another and makes investors cranky for no fundamental reason.

Talent costs. Cleared engineers don’t grow on trees. If wages sprint faster than pricing until contracts reprice, margins feel it.

The defense world eventually resets rates, but “eventually” can be a few quarters.

Competitive gravity. Primes can bundle. Platform software vendors can pitch glossy AI suites.

Niche point solutions can undercut on an intake form.

The antidote is being on time, on spec, on mission, again and again. Execution is the moat.

Valuation Reality Check

At roughly $526 per share, CACI is up ~28% year to date and trades near 23–24× trailing earnings (call it ~19–20× forward).

For multi-year visibility, mid-teens returns on reinvested cash, and free cash flow stepping up toward >$700M, that multiple is neither clearance-sale cheap nor priced for perfection.

If growth moderates more than guided, the multiple can glide toward the high-teens, and the backlog and cash generation cushion the fall.

If award cadence re-accelerates, the current valuation leaves room for upside without needing a fairy tale.

Speaking of cash: the FCF bridge matters.

When free cash flow lifts from the high-$500Ms into the $700M-plus lane, buyback math stops being hypothetical.

Retiring a couple of percent of share count annually while earnings march higher is how you compound quietly.

How I’d Actually Play It

No need to cosplay as a day trader. This one rewards calm accumulation.

Start small on routine softness, think $510–$515, and add if the 10-week/50-day averages hold on market wobbles.

Treat ~2% as a sensible starter position within a diversified book; let results earn the right to scale toward 3–3.5% over time.

If you insist on a hard risk line for a trading sleeve, $490–$495 sits just below recent support without overreacting to headline jitters.

Long-only folks can let position size, not tight stops, manage risk.

The Checklist I’m Watching

I’m not waiting for perfection; I’m looking for consistency:

• Book-to-bill above ~1.05× for a couple of quarters. That says awards are outpacing burn.

• Backlog growth is back to positive year over year, even low single digits. Stability is fine; a nudge up is confidence.

• Free cash flow tracking to that >$700M marker without needing an end-of-year miracle.

• Mix tilt toward software-heavier or higher-complexity awards (cyber, EW, space ground). That tends to help margins and stickiness.

Hit two of the four and I’ll lean in. Hit all four and I’ll likely move the position from good to core-adjacent.

The Tape, Translated

Yes, CACI shares ran on the beat and the FCF talk. No, you don’t need to chase. This is not a miss it and it doubles tomorrow situation.

The chart prefers stair steps over moon shots; pullbacks to rising moving averages have been decent entry points.

If you see a gentle drift lower on light volume after a rally, that’s usually dip-buyers stretching.

If you see heavy volume selling into no news, wait a few sessions, as the government calendar tends to produce explainers after the fact.

What a Reasonable Bear Case Looks Like

Two sluggish award quarters in a row, backlog dips again, growth angles down another point, and the multiple compresses toward 18–19×.

In that script, $460–$485 is a plausible way station. If fundamentals remain intact, long-horizon investors usually use that to average in.

If, instead, we saw material program losses or sustained margin drift into the low-10s, I’d step back and reassess the thesis, not the price.

What a Reasonable Bull Case Looks Like

Award cadence perks up, margins hold, free cash flow lands ahead of plan, and management tucks in a neat capability acquisition that extends competitive edge in spectrum ops or cyber.

Numbers drift higher, the multiple hugs 22–24×, and you’re staring at $600–$625 over the next 12–18 months without needing a funding supercycle.

Final Word: Buy the Yawn, Not the Yell

This is the anti-headline stock. Multi-year work is already in hand. Execution is culturally non-negotiable.

Free cash flow is rising. The multiple is fair. While the market chases the next shiny AI soliloquy, this contractor keeps turning backlog into bank deposits.

If you want lottery tickets, move along. If you want a steady compounding engine tied to real missions, this belongs on your shortlist.

TL;DR

• Setup: Low-drama defense IT with a skyscraper of backlog, tidy execution, and free cash flow stepping up.

• Plan: Accumulate on calm dips ($510–$515), add at moving-average holds; start ~2%, earn up to 3–3.5%.

• Proof: Book-to-bill >1.05×, backlog growth positive, FCF tracking >$700M, mix tilting to higher-value work.

• Ranges: Downside $460–$485 on timing slippage; upside $600–$625 on award cadence and cash beats.

• Mindset: Be patient. Buy the yawn. Let the math do the bragging.